ABBV

AbbVie Inc. ·NYSE·Healthcare
248.66 live · 2026-08-12 15:59

Some scores are at the bottom of their range

This score sits at the bottom of the 0–100 range. The underlying calculation was negative, so the displayed value is a floor, not a measurement of zero.

  • Tactical Score: displayed 0, underlying value -3.1
35.0%
Brown Bear Score
62.1%
Business Conviction Score
20.6%
Position Health Score
23.7%
Chase Risk
Daily closes

Daily closes · 1Y (252 sessions) · +25.2% · range 197.38–263.30

The Businesswhat the company reports

Business & cash flow

FCF / assets 13.3%
OCF / assets 14.2%
FCF / revenue 31.1%
Gross margin 72.8%
ROIC 10.5%
Forward P/E 15.3

FCF/assets and OCF/assets are the cash-flow measures Brown Bear's own testing found to survive; FCF/revenue is shown alongside for context. Assets are from the latest annual filing (FY2025).

Price vs Earnings growth

Forward EPS growth has outpaced trailing price return by +335.8pp

Confidence 95.0/100

Takeaway Earnings growth is outpacing price — consistent with the stock not yet fully reflecting its improving forward estimates.

Reported earnings

Next report 2026-10-29 · consensus EPS 3.92

Q2 23 revenue: 13.87bnQ2 23 net income: 2.02bnQ2 23 EPS: 1.14Q3 23 revenue: 13.93bnQ3 23 net income: 1.78bnQ3 23 EPS: 1.00Q3 23Q4 23 revenue: 14.30bnQ4 23 net income: 822.00mQ4 23 EPS: 0.46Q1 24 revenue: 12.31bnQ1 24 net income: 1.37bnQ1 24 EPS: 0.77Q1 24Q2 24 revenue: 14.46bnQ2 24 net income: 1.37bnQ2 24 EPS: 0.77Q3 24 revenue: 14.46bnQ3 24 net income: 1.56bnQ3 24 EPS: 0.88Q3 24Q4 24 revenue: 15.10bnQ4 24 net income: -22.00mQ4 24 EPS: -0.01Q1 25 revenue: 13.34bnQ1 25 net income: 1.29bnQ1 25 EPS: 0.73Q1 25Q2 25 revenue: 15.42bnQ2 25 net income: 938.00mQ2 25 EPS: 0.53Q3 25 revenue: 15.78bnQ3 25 net income: 186.00mQ3 25 EPS: 0.10Q3 25Q4 25 revenue: 16.62bnQ4 25 net income: 1.82bnQ4 25 EPS: 1.02Q1 26 revenue: 15.00bnQ1 26 net income: 695.00mQ1 26 EPS: 0.39Q1 26

Revenue Net incomeEPS (GAAP) (-0.01–1.14, own scale) Derived Q4

12 quarters to Q1 26. Revenue and net income share one scale, so the gap between them is the margin. The baseline is zero — bars below it are losses. The line is GAAP EPS — it spans every quarter shown, where the reported figure only goes back as far as the consensus feed does.

Quarter endingRevenueYoY Net incomeEPS (GAAP) EPS reportedvs consensus Filed
2026-03-31 15.00bn +12.4% 695.00m 0.39 2.65 +0.2% 2026-05-08
2025-12-31 (derived) 16.62bn +10.0% 1.82bn 1.02 2.71 +0.2% 2026-02-20
2025-09-30 15.78bn +9.1% 186.00m 0.10 1.86 +2.7% 2025-11-04
2025-06-30 15.42bn +6.6% 938.00m 0.53 2025-08-04

Earnings response

Typical move around a filing ±1.3%
On an ordinary two days ±1.2% — filings move it 1.1× as much
Direction 10 up, 1 down over 11 filings
Revenue change and price reaction, by quarter
Q3 22 revenue +3.3% year on yearQ3 22 filed 2022-11-04: price +2.5%Q1 23 revenue -9.7% year on yearQ1 23 filed 2023-05-05: price +0.1%Q1 23Q2 23 revenue -4.9% year on yearQ2 23 filed 2023-08-07: price +1.3%Q3 23 revenue -6.0% year on yearQ3 23 filed 2023-11-06: price +0.5%Q3 23Q1 24 revenue +0.7% year on yearQ1 24 filed 2024-05-03: price +1.2%Q2 24 revenue +4.3% year on yearQ2 24 filed 2024-08-07: price +2.5%Q2 24Q3 24 revenue +3.8% year on yearQ3 24 filed 2024-11-04: price -0.9%Q1 25 revenue +8.4% year on yearQ1 25 filed 2025-05-09: price +2.4%Q1 25Q2 25 revenue +6.6% year on yearQ2 25 filed 2025-08-04: price +1.7%Q3 25 revenue +9.1% year on yearQ3 25 filed 2025-11-04: price +2.3%Q3 25Q1 26 revenue +12.4% year on yearQ1 26 filed 2026-05-08: price +0.0%

Revenue up year on year Revenue down Price move around the filing separate scales — a crossing means nothing

Quarter endingFiledRevenue YoY Move around filingNext 20 sessions vs SPY
2026-03-31 2026-05-08 +12.4% +0.0% +11.5%
2025-09-30 2025-11-04 +9.1% +2.3% +4.5%
2025-06-30 2025-08-04 +6.6% +1.7% +4.2%
2025-03-31 2025-05-09 +8.4% +2.4% -3.7%

Share count

Diluted shares over time

Diluted shares Return since the previous filing

Direction Flat — little net change
Diluted shares 1,774.0M as at 2026-03-31
Change over 1 year +0.1%
Change over 3 years -0.1%
Public float $325.06bn as at 2025-06-30 (10-K)

The Pricewhat the chart is doingTop ↑

Price Levels

StrategyAt Support Zone
Reference band 239.71 — 246.98
Protective stop 228.50 (Atr, 6.1% risk)
Support 242.14 (2 touches, 2.7% away)
Resistance 261.30 (5.0% away)

Takeaway The shares are nearer the floor than the ceiling: about 2.7% above 242.14, a price buyers have stepped in at before, and 5.0% below 261.30, where sellers have turned up before. That floor has held 2 times, which is how it was spotted. If someone bought at today's price and sold if it dropped through the level below, they would be about 6.1% out of pocket. That is all this figure means — an illustration of the risk, not a price to sell at.

Levels are computed from price structure. They describe where the engine locates support and extension — they are not targets, and not advice.

Ichimoku Cloud (Adaptive)

Daily cloudPrice ABOVE the cloud | periods 6/18/36 (70% of classic 9/26/52)
LinesTenkan/Kijun BEAR (fresh down cross, 3d ago) | cloud twist BULL
Cloud eventFresh up breakout 1d ago
Cloud thickness13% percentile (thin — little structure to fight through)
Chikou spanNot clear of price from 26 periods ago
Weekly cloudPrice ABOVE the weekly cloud (context only, not scored)

Takeaway The stock is trading above its cloud — a shaded band drawn from several of its own moving averages, currently 244.71 to 248.00. Being above it means the medium-term picture is pointing upwards, and that band is the first place the stock has recent support if it slips back. Its shorter-term averages point the other way, so this is a mixed reading rather than a clear one.

Trailing returns

21 days +0.3%
63 days +22.7%
126 days +11.4%
252 days +25.6%
Below 252d high5.5%

Trend context

PositionFar above trend
ExtensionExtremely extended
Trend slopeFlat
Direction of travelConverging back to trend

Takeaway Extreme upside extension above Kalman fair trend; entry risk is elevated.

Volatility

State No recent compression
Current band width10.0% of price
Recent tightest8.2% (7 sessions ago, narrower than 71.0% of its history)
Expansion since1.22×
Band 239.66 — 264.89

Takeaway Lately this share price has been swinging around inside a range roughly 10% wide. That is normal for this stock, so there is nothing unusual to read into it either way.

Historical trends

0255075100Share price 246.04–259.222026-07-022026-08-12
Position Health Business Conviction Share price

History begins when the site started recording, not when the company listed, so a short line means a short record and nothing more.

Repair Pathway

  1. Nearest Trigger EMA20 reclaim +0.3% gap is improving · Broadly stable
  2. Trigger 2 Volume confirmation above 1.2x +0.20x volume confirmation would improve confidence in the pathway · Broadly stable
  3. Trigger 3 MACD bullish crossover repair trigger repair engine identifies this as the nearest technical repair catalyst · Improving
  4. Trigger 4 MACD repair streak continuation 3 improving bars MACD histogram has improved for 3 consecutive sessions · Improving
  5. Trigger 5 MACD histogram above zero 1.78 gap is improving · Improving

Who's Tradingthe flow behind the priceTop ↑

Insider activity

ActivityNo filings in the window
Buy filings0
Sell filings0

Open-market Form 4 purchases and sales over the last 75 days, read from SEC EDGAR Form 4. Grants, option exercises, gifts and shares withheld for tax are excluded — they are compensation mechanics, not a decision to buy or sell. Reported Form 4 activity. Brown Bear tested insider cluster-buying as a return signal and rejected it as era-unstable; shown as fact, not signal.

Volume confirmation

Volume-price trend Above its signal line
Confirmation Marginal

No absorption or distribution event in the recent window.

Takeaway Slightly more shares change hands on rising days than on falling ones, but the gap is too small to read anything into.

Options Positioning

No binary-event flag

ABBV: no binary-event flag. Near IV 25%, far IV 26% (ratio 0.93), implied move 3.1%.

Implied volatility 25% near (9d) · 26% far (65d)
Term structure 0.93× near/far
Historical volatility 26%
Implied vs historical 0.95×
Implied move ±3.1% by 2026-08-21
Implied move vs ATR 0.43×
Skew Flat (1.07×)
Put wall 135.00 (-45.7% away)
Gamma pin 135.00

Takeaway Insuring against a move in this stock costs less for the next few weeks than for the next few months, which is the normal state of affairs and suggests no particular date is worrying anyone. Options traders are positioned for a move of around 3.1% in either direction by 2026-08-21.

Chain as at 2026-08-12. This is a risk read on whether a specific event is being priced — not a directional view.

Context & Methodthe record, and how it was builtTop ↑

Relative Rotation

ImprovingLeadingLaggingWeakeningvs sectorvs SPYsector vs SPYRS-Ratio →RS-Momentum →

Stock Rotation Headwind

Rotation health 21.2/100; Severe Rotation Headwind.

Rotation health 21.2
Rotation strength 73.5
LegQuadrantRS-RatioRS-Mom
Stock vs sector Lagging 77.7 93.8
Stock vs SPY Lagging 79.2 98.5
Sector vs SPY Improving 86.4 102.1

Direction of travel: South-West / deteriorating rotation

Position only. Brown Bear's RRG redesign programme is closed — five constructions, none beat an appropriate null — so this section describes where the name sits, and is not a signal.

News Headlines

  1. Loading headlines\u2026

Headlines are supplied by third-party feeds and are not written, ranked or interpreted by Brown Bear. They feed no score on this page.

Detailed Scoring

Positive signals

  • Piotroski F-score 6/9 (+15.0)
  • Gross margin quality: 72.8% (+19.4)
  • ROIC quality: 10.5% (+4.7)
  • FCF margin quality: 31.1% (+20.0)
  • Gross margin improving by 2.8 pts (+2.0)
  • ROIC improving by 3.7 pts (+2.0)
  • FCF margin improving by -2.3 pts (+-3.0)
  • High earnings quality (accrual ratio -0.111) (+8.0)
  • Accrual ratio improving (-0.11 -> -0.11) (+5.0)
  • Track 1: relative momentum rank 0.64 (+2.2)
  • Track 1: MACD histogram acceleration 0.55 (+7.0)
  • Track 1: VPT strength 0.01 (+0.1)
  • Track 1: price above EMA50 by 2.6% (+1.6)
  • Track 1: EMA50 slope improving 1.3% (+2.6)
  • Track 1: EMA50 support proximity 2.6% (+2.9)
  • Track 1: Bollinger position 0.36 (+5.1)
  • Regime convergence: SUPPORT_RESISTANCE_BOUNCE confidence 60.0/100 (EMERGING) (+12.0)

Negative signals

  • Track 1: weak MACD histogram (-1.78)
  • Track 1: weak volume confirmation (0.52x average)
  • Relative strength versus sector deteriorating
  • Track 1: negative 20-day momentum acceleration (-0.06)
  • Track 1: bearish DI spread (-8.0)
  • Track 1: price below EMA20 by 0.3%
  • Track 1: EMA20 slope deteriorating -0.7%
  • Track 1: weak MACD line/signal structure (-5.0)
  • Track 1: MACD slope deteriorating (-5.0)
  • Track 1: RSI deterioration/extension 44.8, 5-day change -4.9
  • Below-average Altman Z-score (2.33)

Chase risk is not elevated for this name, so extension penalties are omitted from the negative signals above.